Science Explorer Back to mapMap
Discussion
Researcher · Institut Claudius Regaud · France

Jean‐Pierre Delord

Jean‐Pierre Delord publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Colorectal Cancer Treatments and Studies.

ORCID 0000-0001-7305-5561 OpenAlex
World rank
#176,607
of 7,710,434 ranked researchers
Rank in France
#11,921
of 324,115
Works
501
Citations
24k
Citations per work
47.5
h-index
66
i10-index 203Top 1.6% in Oncology
Jean‐Pierre Delord

What does Jean‐Pierre Delord research?

Jean‐Pierre Delord's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (7%).

Health Sciences: 233 works · 46.5% of their workMedicine: 233 works · 46.5% of their workOncology: 149 works · 29.7% of their workPulmonary and Respiratory Medicine: 56 works · 11.2% of their workSurgery: 28 works · 5.6% of their workEverything else: 164 works · 32.7% of their workLife Sciences: 104 works · 20.8% of their workBiochemistry, Genetics and Molecular Biology: 71 works · 14.1% of their workMolecular Biology: 50 works · 9.9% of their workCancer Research: 21 works · 4.2% of their workImmunology and Microbiology: 34 works · 6.7% of their workImmunology: 34 works · 6.7% of their workTHEIR WORKJean‐PierreDelord501works
Life Sciences21%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine23346.5%
  2. Everything else16432.7%
    1. Biochemistry, Genetics and Molecular Biology7114.1%
    2. Immunology and Microbiology346.7%
  1. 1Oncology30% of their works
  2. 2Pulmonary and Respiratory Medicine11% of their works
  3. 3Molecular Biology10% of their works
  4. 4Immunology7% of their works
  5. 5Surgery6% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Jean‐Pierre Delord's research?

The keywords of their largest research topics: Chemotherapy, Targeted Therapy, Clinical Trials, Cetuximab, Immune Checkpoint Blockade, PD-1 and PD-L1, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy1584 topics
  2. Targeted Therapy1273 topics
  3. Clinical Trials972 topics
  4. Cetuximab912 topics
  5. Immune Checkpoint Blockade851 topic
  6. PD-1 and PD-L1851 topic
  7. ALK Inhibitors661 topic
  8. EGFR Mutations661 topic
  9. Fluorouracil531 topic
  10. KRAS Mutations531 topic
  11. Chemotherapy-Induced Peripheral Neuropathy421 topic
  12. Taxanes421 topic
  13. Human Papillomavirus381 topic
  14. Oropharyngeal Cancer381 topic
  15. Breast Cancer361 topic
  16. HER2361 topic
  17. Genomic Profiles311 topic
  18. Small-Cell Lung Cancer311 topic
  19. Cancer Genomics301 topic
  20. Mutational Signatures301 topic

Where does Jean‐Pierre Delord work?

Jean‐Pierre Delord's main affiliation in the publication record is Institut Claudius Regaud, France.

How many publications and citations does Jean‐Pierre Delord have?

OpenAlex counts 501 works and 23,780 citations for Jean‐Pierre Delord, an h-index of 66, ranking #176,607 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Jean‐Pierre Delord

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jean‐Pierre Delord. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.